Effects of Resveratrol on Hepatitis B Virus Replication: In vitro and in vivo Experiments

被引:10
|
作者
Pan, Peipei [1 ]
Li, Jiaohui [2 ]
Lin, Wei [3 ]
Long, Guangyan [1 ]
机构
[1] First Peoples Hosp Wenling, Dept Infect Dis, Wenling, Peoples R China
[2] Taizhou Canc Hosp, Dept Internal Med 1, Taizhou, Peoples R China
[3] First Peoples Hosp Wenling, Dept Resp Med, Wenling, Peoples R China
关键词
Hepatitis B virus; Resveratrol; miR-155; Autophagy; Virus replication; ACTIVATION;
D O I
10.1159/000525807
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Hepatitis B virus (HBV) infection is a disease with high incidence and lack of effective treatment. In this study, we further explored the mechanism of resveratrol (RVT) in the inhibition of HBV replication. The effects of RVT on HBV replication were verified using in vitro and in vivo experiments. Methods: HepG2 and HepG2.2.15 cell lines were cultured in vitro, and different concentrations of RVT were used to determine its effect on the proliferation of the two cell lines. Autophagy agonists and inhibitors were given, and whether RVT exerts its effect on the proliferation of HepG2 and HepG2.2.15 cells through autophagy was determined. Reverse transcription-quantitative polymerase chain reaction and Western blot were used to detect changes in autophagy-related factors LC3-II, LC3-I, Beclin 1, and p62. Through transfection of pmiR-155, shmiR-155, and the corresponding control group, the relevant mechanism of RVT in inhibiting the proliferation of HepG2 and HepG2.2.15 cells was analyzed. RVT inhibited the toxicity for HepG2.2.15 cells and reduced HBV replication in vitro (p < 0.05). This effect of RVT was enhanced by rapamycin (RAPA; autophagy activator; p < 0.05) but was partially reversed by 3-MA (autophagy inhibitor; p < 0.05). In addition, our results showed that miR-155 expression was higher in HepG2.2.15 cells than in HepG cells (p < 0.05). miR-155 expression in the RVT treatment group was significantly reduced (p < 0.05). We designed an miR-155 overexpression plasmid, low miR-155 expression plasmid, and the corresponding negative control for transfection and found that transfection of pmiR-155 can partially reverse the effect of RVT (p < 0.05), while transfection with shmiR-155 can enhance the effect of RVT (p < 0.05). Discussion: RVT inhibits miR-155, activates autophagy, inhibits the toxicity for HepG2.2.15 cells, and reduces HBV replication, providing a new research direction for the treatment of HBV infection.
引用
收藏
页码:206 / 214
页数:9
相关论文
共 50 条
  • [11] Impact of steroids on hepatitis c virus replication in vivo and in vitro
    Metselaar, Herold J.
    Henry, Scot D.
    van Dijck, Jeroen
    Tilanus, Hugo W.
    van der Laan, Luc J. W.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 286 - 286
  • [12] Impact of steroids on hepatitis C virus replication in Vivo and in Vitro
    Henry, Scot D.
    Metselaar, Herold J.
    Van Dijck, Jeroen
    Tilanus, Hugo W.
    Van Der Laan, Luc J. W.
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 439 - 447
  • [13] Inhibition of the Replication of Hepatitis B Virus In Vitro by Oxymatrine
    Lin, M.
    Yang, L. Y.
    Li, W. Y.
    Peng, Y. P.
    Zheng, J. K.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (05) : 1411 - 1419
  • [14] Inhibition of the replication of hepatitis B virus in vitro by emodin
    Dang Shuangsuo
    Zhang Zhengguo
    Chen Yunru
    Zhang Xin
    Wang Baofeng
    Yuan Lichao
    Cheng Yan'an
    MEDICAL SCIENCE MONITOR, 2006, 12 (09): : BR302 - BR306
  • [15] Inhibition of replication of hepatitis B virus by cytallene in vitro
    Zhu, YL
    Pai, SB
    Liu, SH
    Grove, KL
    Jones, BCNM
    Simons, C
    Zemlicka, J
    Cheng, YC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1755 - 1760
  • [16] The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro
    Bock, CT
    Malek, NP
    Tillmann, HL
    Manns, MP
    Trautwein, C
    JOURNAL OF VIROLOGY, 2000, 74 (05) : 2193 - 2202
  • [17] Characterization of microRNA expression profiles associated with hepatitis B virus replication and clearance in vivo and in vitro
    Pan, Xiao-Ben
    Ma, Hui
    Jin, Qian
    Wei, Lai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (04) : 805 - 812
  • [18] The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo
    Wan-Yu Li
    Ji-Hua Ren
    Na-Na Tao
    Long-Kuan Ran
    Xiang Chen
    Hong-Zhong Zhou
    Bo Liu
    Xiao-Song Li
    Ai-Long Huang
    Juan Chen
    Archives of Virology, 2016, 161 : 621 - 630
  • [19] The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo
    Li, Wan-Yu
    Ren, Ji-Hua
    Tao, Na-Na
    Ran, Long-Kuan
    Chen, Xiang
    Zhou, Hong-Zhong
    Liu, Bo
    Li, Xiao-Song
    Huang, Ai-Long
    Chen, Juan
    ARCHIVES OF VIROLOGY, 2016, 161 (03) : 621 - 630
  • [20] Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro
    Wang, Yawen
    Li, Yiping
    Li, Na
    Zhu, Qianqian
    Hui, Lingyun
    Liu, Xi
    Han, Qunying
    Lv, Yi
    Wang, Quanying
    Yang, Guangxiao
    Zhou, Zhihua
    Liu, Zhengwen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 25 (02) : 363 - 369